APA (7th ed.) Citation

Templin, A. T., Mellati, M., Soininen, R., Hogan, M. F., Esser, N., Castillo, J. J., . . . Hull, R. L. (2019). Loss of perlecan heparan sulfate glycosaminoglycans lowers body weight and decreases islet amyloid deposition in human islet amyloid polypeptide transgenic mice. PEDS: Protein Engineering, Design & Selection, 32(2), 95. https://doi.org/10.1093/protein/gzz041

Chicago Style (17th ed.) Citation

Templin, Andrew T., Mahnaz Mellati, Raija Soininen, Meghan F. Hogan, Nathalie Esser, J Josh Castillo, Sakeneh Zraika, Steven E. Kahn, and Rebecca L. Hull. "Loss of Perlecan Heparan Sulfate Glycosaminoglycans Lowers Body Weight and Decreases Islet Amyloid Deposition in Human Islet Amyloid Polypeptide Transgenic Mice." PEDS: Protein Engineering, Design & Selection 32, no. 2 (2019): 95. https://doi.org/10.1093/protein/gzz041.

MLA (9th ed.) Citation

Templin, Andrew T., et al. "Loss of Perlecan Heparan Sulfate Glycosaminoglycans Lowers Body Weight and Decreases Islet Amyloid Deposition in Human Islet Amyloid Polypeptide Transgenic Mice." PEDS: Protein Engineering, Design & Selection, vol. 32, no. 2, 2019, p. 95, https://doi.org/10.1093/protein/gzz041.